Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Ube2tem1flox/Cya
Common Name:
Ube2t-flox
Product ID:
S-CKO-13557
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Ube2t-flox
Strain ID
CKOCMP-67196-Ube2t-B6J-VA
Gene Name
Ube2t
Product ID
S-CKO-13557
Gene Alias
2700084L22Rik
Background
C57BL/6JCya
NCBI ID
67196
Modification
Conditional knockout
Chromosome
1
Phenotype
MGI:1914446
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Ube2tem1flox/Cya mice (Catalog S-CKO-13557) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000027687
NCBI RefSeq
NM_026024
Target Region
Exon 3
Size of Effective Region
~1.0 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Ube2t, the ubiquitin-conjugating enzyme E2T, plays a crucial role in the ubiquitination process, which is involved in various cellular functions such as protein degradation, DNA repair, and cell cycle regulation. It interacts with different E3 ubiquitin ligases and is associated with multiple signaling pathways like the p53, Akt/β-catenin, and Wnt/β-catenin pathways, and is of great biological importance in cell survival, proliferation, and tumorigenesis [1-10]. Genetically modified mouse models, including knockout (KO) and conditional knockout (CKO) models, have been instrumental in studying Ube2t.

In pancreatic cancer, Ube2t-conditional knockout (CKO) in spontaneous PC mice (KPC) showed a marked survival advantage after gemcitabine treatment. Ube2t levels were positively correlated with gemcitabine resistance. Mechanistically, Ube2t catalyzes RING1-mediated ubiquitination of p53, relieving transcriptional repression of ribonucleotide reductase subunits, promoting pyrimidine biosynthesis, and alleviating replication stress [1]. In hepatocellular carcinoma, knockdown of Ube2t in xenograft tumor models reduced radioresistance. Ube2t-RNF8 complex monoubiquitinated H2AX/γH2AX upon radiation, facilitating CHK1 activation for DNA repair [2]. In glioblastoma, knockdown of Ube2t in LN229 xenograft mouse models suppressed tumor growth. Ube2t induced ubiquitination-mediated degradation of RPL6, promoting malignancy [3]. In breast cancer, Ube2t inhibition in mice suppressed tumor growth by promoting DNA replication stress, cell cycle arrest, and apoptosis [5]. In retinoblastoma, knockdown of Ube2t inhibited subcutaneous tumor growth in vivo, reducing cell viability and increasing apoptosis [4]. In glioblastoma, Ube2t knockdown sensitized cells to temozolomide (TMZ), and in a xenograft mouse model, Ube2t facilitated TMZ resistance by activating the Wnt/β-catenin pathway [6].

In conclusion, model-based research, especially through Ube2t KO/CKO mouse models, has revealed that Ube2t is involved in promoting tumor growth, drug resistance, and radioresistance in multiple cancer types. These findings suggest that targeting Ube2t could be a potential therapeutic strategy for treating pancreatic, liver, brain, breast, and eye cancers, among others.

References:
1. Jiang, Xiangyan, Ma, Yong, Wang, Tao, Yu, Zeyuan, Jiao, Zuoyi. 2023. Targeting UBE2T Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Regulating Pyrimidine Metabolism and Replication Stress. In Gastroenterology, 164, 1232-1247. doi:10.1053/j.gastro.2023.02.025. https://pubmed.ncbi.nlm.nih.gov/36842710/
2. Sun, Jingyuan, Zhu, Zhenru, Li, Wenwen, Liu, Li, Wu, Dehua. 2020. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation. In Journal of experimental & clinical cancer research : CR, 39, 222. doi:10.1186/s13046-020-01734-4. https://pubmed.ncbi.nlm.nih.gov/33087136/
3. Tao, Xuxiu, Wu, Xia, Zhou, Peijun, Peng, Jinwu, Yang, Lifang. 2022. UBE2T promotes glioblastoma malignancy through ubiquitination-mediated degradation of RPL6. In Cancer science, 114, 521-532. doi:10.1111/cas.15604. https://pubmed.ncbi.nlm.nih.gov/36156329/
4. Xu, Nuo, Cui, Yi, Shi, Hong, Jian, Tianming, Rao, Huiying. . UBE2T/STAT3 Signaling Promotes the Proliferation and Tumorigenesis in Retinoblastoma. In Investigative ophthalmology & visual science, 63, 20. doi:10.1167/iovs.63.9.20. https://pubmed.ncbi.nlm.nih.gov/35980647/
5. Dutta, Roshan, Guruvaiah, Praveen, Reddi, Kiran Kumar, Singh, Kamaljeet, Gupta, Romi. 2022. UBE2T promotes breast cancer tumor growth by suppressing DNA replication stress. In NAR cancer, 4, zcac035. doi:10.1093/narcan/zcac035. https://pubmed.ncbi.nlm.nih.gov/36338541/
6. Wang, Yang, Gao, Ge, Wei, Xiangpin, Zhang, Yang, Yu, Jian. 2023. UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway. In Drug design, development and therapy, 17, 1357-1369. doi:10.2147/DDDT.S405450. https://pubmed.ncbi.nlm.nih.gov/37181827/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest